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Radiopharmaceuticals are used to diagnose and treat a number of diseases such as 
bone cancer and non-Hodgkin’s lymphoma.  A radiopharmaceutical typically 
consists of a targeting molecule that selectively targets certain tumors.  The 
targeting molecule is labeled with a radioactive atom(s) that delivers a dose of 
radiation to the tumor.  The radioactive properties of Au-198 (β- = 0.96 MeV; γ = 
411 KeV) and Au-199 (β- = 0.45 MeV; γ = 158 KeV) with their beta (therapeutic) 
and gamma (imaging) emission make them valuable candidates for both 
therapeutic and imaging applications.  Gold nanoparticles have several properties 
that make them particularly interesting for use in radiopharmaceuticals.  They are 
stable in vivo, have multiple atoms per particle and are small enough in size to 
deliver a radioactive dose directly to cancer cells.  The purpose of this study was to 
gain a better understanding of the binding properties of the nanoparticles with 
reducing and stabilizing agents.  This knowledge will aid in future attempts to label 
the particles with various antibodies and peptides for tumor targeted delivery of the 
drug. Next, investigate the relationship between particle size and the amount of 
reducing agent used was studied with varying amounts and types of carbohydrate 
stabilizers. Our goal is to establish a library of nanoparticles with varying sizes that 
can be conjugated with different biomolecules that are selective for receptors over 
expressed by the diseased tissue. In future studies we also plan to pursue an 
indirect method of preparing radioactive Au-199 nanoparticles at carrier free levels 
from beta decay of Pt-199. 
 
